|  ï»¿Drug Name  | Drug Bank  | MOA  | Experiments  | Methods  | Parameter  | Mean  | Unit  | 
| ---- | --- | --- | --- | --- | --- | --- | --- | 
|  Remdesivir  | https://www.drugbank.ca/drugs/DB14761  | Nucleobindin-1 (NUCB1) Inhibitors  | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO  | Viral replication assay  | IC-50  | 1.00E-08  | M  | 
|  Emetine  | https://www.drugbank.ca/drugs/DB13393  | Platelet-Derived Growth Factor (PDGF) Inhibitors;Signal Transduction Modulators;Angiogenesis Inhibitors  | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO  | Cytopathicity assay  | IC-50  | 1.50E-07  | M  | 
|  Nafamostat mesilate  | https://www.drugbank.ca/drugs/DB12598  | Tryptase Inhibitors  | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO  | Vero cells (TMPRSS2-expressing) transfected with MERS  | IC-50  | 1.00E-09  | M  | 
|  Alisporivir  | https://www.drugbank.ca/drugs/DB12139  | P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Cyclophilin Inhibitors  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | RNA assay  | IC-50  | 8.00E-07  | M  | 
|  Lycorine  | https://www.drugbank.ca/drugs/DB11231  |   | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO  | Dye assay  | IC-50  | 1.57E-08  | M  | 
|  Niclosamide  | https://www.drugbank.ca/drugs/DB06803  | Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors  | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO  | Cytopathicity assay  | IC-50  | 1.00E-07  | M  | 
|  Rupintrivir  | https://www.drugbank.ca/drugs/DB05102  | HRV 3C Protease Inhibitors  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | Viral replication assay  | IC-50  | 3.00E-07  | M  | 
|  Geldanamycin  | https://www.drugbank.ca/drugs/DB02424  | Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors  | Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO  |   | IC-50  | 9.10E-07  | M  | 
|  Sinefungin  | https://www.drugbank.ca/drugs/DB01910  | Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators  | Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO  |   | IC-50  | 3.83E-07  | M  | 
|  Mycophenolic acid sodium salt  | https://www.drugbank.ca/drugs/DB01024  | Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors  | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO  | Cytopathicity assay  | IC-50  | 1.70E-07  | M  | 
|  Mycophenolate mofetil  | https://www.drugbank.ca/drugs/DB00688  | Hydroxycarboxylic Acid Receptor 2 (HCAR2; NIACR1; GPR109A) Agonists;Signal Transduction Modulators;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | Viral replication assay  | IC-50  | 2.30E-07  | M  | 
|  Chloroquine  | https://www.drugbank.ca/drugs/DB00608  |   | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  |   | IC-50  | 8.00E-10  | M  | 
|  Gemcitabine hydrochloride  | https://www.drugbank.ca/drugs/DB00441  | Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | Cytopathicity assay  | IC-50  | 4.40E-07  | M  | 
|  Promazine  | https://www.drugbank.ca/drugs/DB00420  | Signal Transduction Modulators;Dopamine Receptor Antagonists  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | Cytopathicity assay  | MIC  | 1.00E-07  | M  | 
|  Azithromycin  | https://www.drugbank.ca/drugs/DB00207  | Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors  | Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO  | Luciferine/luciferase assay  | IC-50  | 1.00E-07  | M  | 
|  [N-MeIle4]-cyclosporin  | https://www.drugbank.ca/drugs/DB00091  | Cyclophilin Inhibitors;Mitochondrial Permeability Transition (MPT) Inhibitors  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | RNA assay  | IC-50  | 8.00E-07  | M  | 
|  Ciclosporin  | https://www.drugbank.ca/drugs/DB00091  | Cyclophilin D Inhibitors;Signal Transduction Modulators;Serine/Threonine-Protein Phosphatase 2B (PPP3CC; PP2Bgamma; Calcineurin) Inhibitors;INS Expression Inhibitors  | Coronavirus acute respiratory syndrome remission/reduction, IN VITRO  | RNA assay  | IC-50  | 9.00E-07  | M  | 
